Australia's 4DMedical jumps on US FDA approval

4DMedical

19/11/2023 23:40

** Shares of 4DMedical  4DX.AX  up 20.6% to A$0.79, set for
best day since Nov. 13, if gains hold
    ** Medical technology firm says it has received clearance
for its computed tomography-based ventilation product CT LVAS
from the U.S. Food and Drug Administration (FDA)
    ** Says, FDA clearance expands patient accessibility of
functional lung imaging in the U.S.
    ** 4DX stock up ~56% YTD as of last close
 

 (Reporting by Ayushman Ojha in Bengaluru)
 ((Ayushman.ojha@thomsonreuters.com;))